JP2019508018A5 - - Google Patents

Download PDF

Info

Publication number
JP2019508018A5
JP2019508018A5 JP2018531443A JP2018531443A JP2019508018A5 JP 2019508018 A5 JP2019508018 A5 JP 2019508018A5 JP 2018531443 A JP2018531443 A JP 2018531443A JP 2018531443 A JP2018531443 A JP 2018531443A JP 2019508018 A5 JP2019508018 A5 JP 2019508018A5
Authority
JP
Japan
Prior art keywords
peptide
seq
disease
nervous system
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018531443A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019508018A (ja
JP6915810B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2016/050445 external-priority patent/WO2017101956A1/en
Publication of JP2019508018A publication Critical patent/JP2019508018A/ja
Publication of JP2019508018A5 publication Critical patent/JP2019508018A5/ja
Application granted granted Critical
Publication of JP6915810B2 publication Critical patent/JP6915810B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018531443A 2015-12-18 2016-12-19 ＳｏｒＣＳペプチド及びそれらの用途 Expired - Fee Related JP6915810B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201570835 2015-12-18
DKPA201570835 2015-12-18
PCT/DK2016/050445 WO2017101956A1 (en) 2015-12-18 2016-12-19 SorCS PEPTIDES AND USES THEREOF

Publications (3)

Publication Number Publication Date
JP2019508018A JP2019508018A (ja) 2019-03-28
JP2019508018A5 true JP2019508018A5 (cg-RX-API-DMAC10.html) 2020-01-30
JP6915810B2 JP6915810B2 (ja) 2021-08-04

Family

ID=59055867

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018531443A Expired - Fee Related JP6915810B2 (ja) 2015-12-18 2016-12-19 ＳｏｒＣＳペプチド及びそれらの用途

Country Status (4)

Country Link
US (1) US20190345216A1 (cg-RX-API-DMAC10.html)
EP (1) EP3390435A1 (cg-RX-API-DMAC10.html)
JP (1) JP6915810B2 (cg-RX-API-DMAC10.html)
WO (1) WO2017101956A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022029281A1 (en) 2020-08-06 2022-02-10 Aarhus Universitet Cyclic peptides and uses thereof
WO2023152229A1 (en) 2022-02-09 2023-08-17 Teitur Trophics Aps Novel peptides
CN121925267A (zh) 2023-08-16 2026-04-24 泰图尔特罗菲克斯有限公司 用于治疗内耳或乳突疾病的肽类药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1891966T3 (da) * 2002-12-20 2012-04-02 Lundbeck & Co As H Modulation af neurotrophinaktivitet; fremgangsmåde til screening
ES2464459T3 (es) * 2008-06-25 2014-06-02 H. Lundbeck A/S Modulación del sistema receptor Trpv:receptor de dominio Vps 10p para el tratamiento del dolor
EP3165537A1 (en) * 2008-12-19 2017-05-10 H. Lundbeck A/S Modulation of the vps 10-domain receptor family for the treatment of mental and behavioural disorders
US20130336988A1 (en) * 2010-11-17 2013-12-19 New York University Methods for treating early stage or mild neurological disorders

Similar Documents

Publication Publication Date Title
JP2018171063A5 (cg-RX-API-DMAC10.html)
MX2020010806A (es) Peptidos anti-inflamatorios y usos de los mismos.
JP2016525100A5 (cg-RX-API-DMAC10.html)
HRP20140586T1 (hr) Peptidi za lijeäśenje beta-amiloidoze
JP2019519216A5 (cg-RX-API-DMAC10.html)
JP2019500414A5 (cg-RX-API-DMAC10.html)
IL288541B (en) Vaccine against rsv
JP2014501510A5 (cg-RX-API-DMAC10.html)
JP2018510622A5 (cg-RX-API-DMAC10.html)
HRP20231496T1 (hr) Cistein proteaza
JP2017512063A5 (cg-RX-API-DMAC10.html)
JP2016523959A5 (cg-RX-API-DMAC10.html)
NZ628987A (en) Extended recombinant polypeptides and compositions comprising same
JP2017514522A5 (cg-RX-API-DMAC10.html)
JP2019506839A5 (cg-RX-API-DMAC10.html)
JP2012115277A5 (cg-RX-API-DMAC10.html)
RU2013128895A (ru) Улучшенные n-терминальные кэппинг модули для сконструированных белков с анкириновым повтором
WO2009004315A8 (en) Isolated peptides and uses thereof
HRP20161458T1 (hr) Polipeptidi, polinukleotidi i pripravci namijenjeni upotrebi u liječenju latentne tuberkuloze
NZ705899A (en) Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (trem-1) trem-like transcript 1 (tlt-1) and uses thereof
JP2014519526A5 (cg-RX-API-DMAC10.html)
JP2008506357A5 (cg-RX-API-DMAC10.html)
HRP20191965T1 (hr) Stabilizirani polipeptidi faktora rasta slični inzulinu
RU2016152249A (ru) Улучшенная нитрилгидратаза
JP2014510101A5 (cg-RX-API-DMAC10.html)